Clinical Trial Update: A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing neoadjuvant chemoradiotherapy regimens of 5-FU/Leucovorin versus TS-1/Irinotecan in locally advanced rectal cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-FU/leucovorin (5-fluorouracil/leucovorin)
• Irinotecan (Irinotecan)
• TS-1 (tegafur/gimeracil/oteracil) (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED